Metabolic Brain Disease : Impact Factor & More
eISSN: 1573-7365pISSN: 0885-7490
Share this on:
Key Metrics
CiteScore 
5.8
Eigenfactor
0.005 - 0.01
Impact Factor
< 5
SJR
Q2Biochemistry
SNIP
1.02
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Metabolic Brain Disease
Metabolic Brain Disease Journal Specifications
| Overview | |
| Publisher | SPRINGER/PLENUM PUBLISHERS |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 1986 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Metabolic Brain Disease ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Metabolic Brain Disease
MitoQ reducing sevoflurane-induced cognitive dysfunction by modulating mitochondrial dysfunction
- 30 Oct 2025
- Metabolic Brain Disease
Exploring the effects of squalene in the PERK/ATF4/eIF2α/CHOP signalling pathway in an in vitro Alzheimer Disease model and in silico approach.
- 29 Oct 2025
- Metabolic brain disease
From the hive to the brain: synergistic potential of honeybee products with alzheimer's drugs.
- 29 Oct 2025
- Metabolic brain disease
Inhibition of ventral tegmental area projections to the paraventricular thalamus attenuates conditioned cues-induced heroin seeking behavior in rats.
- 27 Oct 2025
- Metabolic brain disease
Polygalasaponin F alleviates cerebral ischemia-reperfusion injury through inhibiting mitophagy.
- 24 Oct 2025
- Metabolic brain disease
Ketamine enhances neurological function through neuronal and plasticity-related protein changes in rats with permanent middle cerebral artery occlusion.
- 24 Oct 2025
- Metabolic brain disease
MitoQ reducing sevoflurane-induced cognitive dysfunction by modulating mitochondrial dysfunction
- 30 Oct 2025
- Metabolic Brain Disease
Exploring the effects of squalene in the PERK/ATF4/eIF2α/CHOP signalling pathway in an in vitro Alzheimer Disease model and in silico approach.
- 29 Oct 2025
- Metabolic brain disease
From the hive to the brain: synergistic potential of honeybee products with alzheimer's drugs.
- 29 Oct 2025
- Metabolic brain disease
Inhibition of ventral tegmental area projections to the paraventricular thalamus attenuates conditioned cues-induced heroin seeking behavior in rats.
- 27 Oct 2025
- Metabolic brain disease
Polygalasaponin F alleviates cerebral ischemia-reperfusion injury through inhibiting mitophagy.
- 24 Oct 2025
- Metabolic brain disease
Ketamine enhances neurological function through neuronal and plasticity-related protein changes in rats with permanent middle cerebral artery occlusion.
- 24 Oct 2025
- Metabolic brain disease
FAQs on Metabolic Brain Disease
How long has Metabolic Brain Disease been actively publishing? 
What is the publishing frequency of Metabolic Brain Disease?
How many articles did Metabolic Brain Disease publish last year?
What is the eISSN & pISSN for Metabolic Brain Disease?
What is Citescore for Metabolic Brain Disease?
What is SNIP score for Metabolic Brain Disease?
What is the SJR for Metabolic Brain Disease?
Who is the publisher of Metabolic Brain Disease?
